SecBot SecBot
SECBOTREPLAY Home › Report › EWTX

EWTX · Fidelity stake 0.9%

Edgewise Therapeutics, Inc. · SC 13G/A filed Nov 5, 2026 at 13:16 ET

At the news

NEUTRALIMPACT 2/10

SC 13G/A filed Nov 5, 2026 at 13:16 ET

FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 970,920 shares of Edgewise Therapeutics common stock as of September 30, 2026, representing 0.9% of shares outstanding. This is a routine passive stake update filed one day after Edgewise reported Q3 results that included a large one-time gain from the sale of sevasemten. The stake is unchanged from the prior filing, and the filing carries no directional signal.

  • FMR LLC reported beneficial ownership of 970,920 shares of Edgewise Therapeutics common stock as of September 30, 2026
  • The stake represents 0.9% of shares outstanding
  • This is an amendment to a prior Schedule 13G filed August 6, 2026
  • The filing was made under Rule 13d-1(b) indicating passive investment intent

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access